everydayhealth.com
Dec 17, 2024, 01:39
Akhil Santhosh: The 3-year results of RELATIVITY 047 out in Journal of Clinical Oncology
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X about a recent paper by Hussein Tawbi et al. published in JCO:
“The 3-year results of RELATIVITY 047 out in Journal of Clinical Oncology.
Nivolumab and relatlimab continues to impress. Toxicity profile better than nivo ipi. Interestingly, at the 3 year follow up, upper bound of HR 95% ci is less than 1 for overall survival.”
Authors: Hussein Tawbi et al.
More posts featuring Akhil Santhosh.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 04:19
Feb 22, 2025, 03:56
Feb 22, 2025, 03:52
Feb 22, 2025, 03:21
Feb 22, 2025, 03:18